INCYTE
Manufacturing · Delaware, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1801 Augustine Cut Off, Wilmington, Dela...Phone Number
(302) 498-6700Website
incyte.comRevenue
$5.4 BillionStock Symbol
INCYIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
15
21
1
2
2
2
About INCYTE
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.Explore more
INCYTE Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is INCYTE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at INCYTE
Funding: Get notified immidiatlly once INCYTE has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if INCYTE is spiking on competitors!
INCYTE, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if INCYTE had a recent Job posting/layoffs
Product Launch: Get notified when INCYTE launches new products
Earning: See what the market has to say on INCYTE recently announced quarterly report
Check if INCYTE has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined INCYTE as Masked Content
Find 3 more new buyers
Compare Similar Companies to INCYTE
Compare insights from companies similar to INCYTE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
INCYTE is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
INCYTE is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about INCYTE.
INCYTE Tech Stack
A closer look at the technologies used by INCYTE
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
INCYTE has more open roles in Medical & Health than it has had at any time in the past 12 months with an increased focus that include Immunology, and Dermatology, and experience with Pharmacovigilance, Investigator's Brochure, Oncology, Clinical Trial Development, and Clinical Study Reports.
Hiring Plans
Open Position
Open Position
Open Position
INCYTE News & Media
Incyte bolsters haematology portfolio in $2bn Vega buyout
The Vega acquisition will see Incyte absorb its first-in-class bleeding disorder candidate, VG039.Incyte Corporation (INCY) M&A Call Transcript
Incyte Corporation (INCY) M&A Call June 8, 2026 8:00 AM EDTCompany ParticipantsAlexis Smith - Vice President & Head of Investor RelationsWilliam...Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll Out
Incyte (NASDAQ:INCY) Chief Medical Officer Steven Stein outlined the company’s development priorities across hematology, oncology and immunology, with a particular focus on its mutant CALR antibody 989, during a company news event. Stein said myeloproliferative neoplasms remain “front and center” fIncyte pays Genesis $80M to expand AI-fueled drug discovery pact - Fierce Biotech
Incyte is paying Genesis $80 | Incyte is paying Genesis $80 million upfront to expand use of its partner’s AI platform across a broader range of targets, continuing the biotech’s rapid embrace of AI in drug discovery and development.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INCYTE
Sign Up For FreeTo access detailed company insights
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome... Read More
